Search Results - "Heim, M. E."

Clinical phase I and pharmacokinetic trial of the new titanium complex budotitane by SCHILLING, T, KEPPLER, K. B, HEIM, M. E, NIEBCH, G, DIETZFELBINGER, H, RASTETTER, J, HANAUSKE, A.-R

Get full text

Effects of inpatient rehabilitation on health-related quality of life in breast cancer patients by Heim, M E, Kunert, S, Ozkan, I

“…Major endpoint for the assessment of a complex inpatient rehabilitation program is the health-related quality of life. In a prospective longitudinal study we…”
Get more information

WHO consensus conference on diet and cancer by Meyskens, F L, Jungi, W F, Gerber, M, de Waard, F, Heidemann, E, Heim, M E, Joossens, J-V, Salvini, S, Trichopoulou, A, Varela, G, Wolfram, G

Get full text

Multiple myeloma: effect of daily dichloromethylene bisphosphonate on skeletal complications by Clemens, M R, Fessele, K, Heim, M E

“…In 1989, a prospective randomized multicenter study was initiated in order to determine the safety and efficacy of oral clodronate in myeloma patients. The…”
Get full text

New tumor-inhibiting metal complexes by Keppler, B K, Berger, M R, Heim, M E

Get more information

Cyclic alternating chemotherapy of high-grade malignant non-Hodgkin lymphomas with VIM-Bleo and CHOP by Steinke, B, Bross, K, Reinold, H M, Heim, M E, Schalk, K P, Heidemann, E, Josten, K, Arnold, H, Manegold, C, Hoffman, I

“…Between 1986 and 1988, 81 patients with high grade malignant non-Hodgkin lymphoma according to the Kiel classification were treated with the…”
Get more information

Combined modality of radiation and chemotherapy for the treatment of gastric carcinoma. A review by Queisser, W, Heim, M E

“…The results of combined radiation and chemotherapy for the treatment of gastric carcinoma are reviewed. A small amount of postoperative adjuvant combined…”
Get more information

Tumor necrosis factor for the treatment of malignancies by Hieber, U, Heim, M E

“…Tumor necrosis factor (TNF) is a cytokine produced in vivo by activated macrophages and monocytes with pleiotropic effects on normal and malignant cells. TNF…”
Get more information

Rehabilitation bei Patienten mit Prostatakarzinom by Heim, M. E., Schwerte, U.

Get full text

Combination of recombinant interferon alpha-2A and vinblastine in advanced renal cell cancer by Schuster, D, Schneider, G, Ade, N, Heim, M E

“…Experimental results suggest synergistic activity of interferon with different cytotoxic agents, including vinblastine. Both interferon and vinblastine have…”
Get more information

Central nervous side effects following ifosfamide monotherapy of advanced renal carcinoma by Heim, M E, Fiene, R, Schick, E, Wolpert, E, Queisser, W

“…Ten patients with advanced renal carcinoma were treated by ifosfamide (50-60 mg/kd/day x 5 days). The treatment was repeated every 4 weeks and continued until…”
Get full text

Chemotherapy in alimentary tract malignomas by Queisser, W, Heim, M E

Get more information

Rehabilitation in women with breast cancer-special problems in hereditary diseases by Heim, M E

“…A rehabilitation program for women with high risk for breast cancer or known hereditary breast carcinoma is described. The rehabilitation uses complex and…”
Get more information

Steroid receptor pattern of human colorectal neoplasms by Bojar, H, Heim, M E, Petzinna, D, Staib, W

“…Twenty-four colorectal carcinomas were assayed for estrogen and progestin receptors by sucrose gradient centrifugation. Most biopsies were either completely…”
Get more information

Sequential high dose methotrexate, 5-fluorouracil and folinic acid does not improve response rates in advanced colorectal cancer by Heim, M E, Schuster, D, Flechtner, H, Worst, P, Queisser, W

“…27 patients with advanced colorectal cancer were treated in a phase-II trial with high dose sequential methotrexate (MTX), 5-fluorouracil (5-FU), and folinic…”
Get more information

Randomized crossover study of the antiemetic activity of levonantradol and metoclopramide in cancer patients receiving chemotherapy by HEIM, M. E, QUEISSER, W, ALTENBURG, H.-P

“…In a randomized crossover study 57 cancer patients receiving chemotherapy with high emetic potential were treated with low-dose levonantradol or standard-dose…”
Get full text

5-Fluorouracil, 4-epidoxorubicin, and mitomycin C (FEM) combination chemotherapy for advanced gastric carcinoma. A phase-II trial by the "chemotherapiegruppe gastrointestinaler tumoren (CGT)" by Flechtner, H, Queisser, W, Heim, M E, Henss, H, Arnold, H, Fritze, D, Herrmann, R, Fritsch, H, Fritz, M, Trux, F A

“…In a phase-II-trial 40 patients with advanced gastric cancer were treated with 5-fluorouracil, 4-epidoxorubicin, mitomycin C (FEM) combination therapy…”
Get more information

Fetal gastric and colonic implants in syngeneic and allogeneic mice developing typical inflammatory changes by Heim, M E, Taylor, K B

“…Implants of fetal stomach and colon under the kidney capsule of syngeneic, and H-2 compatible and H-2 incompatible allogeneic mice were examined histologically…”
Get full text

Response-oriented therapy with CHOP and VIM-Bleo in high-grade malignant non-Hodgkin's lymphomas by Steinke, B, Krüger, H U, Kraft, H, Heim, M E, Günther, E, Arnold, H, Busch, F W

“…Twenty four patients with high grade malignant NHL (stage II 8, stage III 4, stage IV 12 patients respectively) were treated with a response-oriented regimen:…”
Get full text

Phase-II studies of 1,2,4-triglycidylurazol (TGU) in solid tumors. Phase-II Study Group of the Association of Medical Oncology of the German Cancer Society by Queisser, W, Wander, H E, Possinger, K, Fiebig, H H, Heim, M E, Peukert, M

Get more information